G&E Herbal Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
November 08, 2022 at 08:40 pm
Share
G&E Herbal Biotechnology Co., Ltd. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was TWD 19.63 million compared to TWD 7.57 million a year ago. Net income was TWD 5.75 million compared to net loss of TWD 3.08 million a year ago. Basic earnings per share from continuing operations was TWD 0.1 compared to basic loss per share from continuing operations of TWD 0.06 a year ago.
For the nine months, sales was TWD 34.53 million compared to TWD 19.42 million a year ago. Net loss was TWD 2.17 million compared to TWD 11.05 million a year ago. Basic loss per share from continuing operations was TWD 0.04 compared to TWD 0.2 a year ago.
G&E Herbal Biotechnology Co., Ltd is a Taiwan-based company principally engaged in the research and development, manufacture and distribution of health care food products, functional skin care products and pharmaceutical products. Its health care food products include accessory food products and capsules for cancer and urogenital disorder. The Company also provides botanical medicines for cancers and liver diseases. The Company distributes its products within domestic market and to overseas markets.
G&E HERBAL BIOTECHNOLOGY CO., LTD. 
